Description
The geneMAP™ BCR-ABL1 p190(mbcr) Detection Kit intended for the quantification of BCR-ABL1 p190(e1a2) transcripts in bone marrow or peripheral blood samples of Ph-positive acute lymphoblastic leukemia (ALL) patients previously diagnosed with a BCR-ABL1 mbcr fusion gene event. The test is intended to evaluate the level of molecular response. This test can be used to monitor Minimal Residual Disease (MRD) in patients undergoing therapy.
Size: 48 tests
Product description
The geneMAP™ BCR-ABL1 p190(mbcr) Detection Kit intended for the quantification of BCR-ABL1 p190(e1a2) transcripts in bone marrow or peripheral blood samples of Ph-positive acute lymphoblastic leukemia (ALL) patients previously diagnosed with a BCR-ABL1 mbcr fusion gene event. The test is intended to evaluate the level of molecular response. This test can be used to monitor Minimal Residual Disease (MRD) in patients undergoing therapy.
Size: 48 tests
Features
- Quantitative determination of BCR-ABL1 fusion gene (p190) e1a2 transcripts.
- Superior analytical sensitivity LOG 4.
- Fast and Easy to use with One Step RT-qPCR technology.
- Primer probe mix, target gene and reference gene (ABL1) are all in one tube (MULTIPLEX).
- ABL1 as a reference gene.
- With the calibrator and conversion constant, your results conform to the International Scale.
- Automatic analysis with geneMAP™ viewer (for CFX96™ / BIO-RAD).
- CE-IVD
- Real-time PCR










